<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Principles of agent selection for PAH-directed therapy in patients with HIV</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Principles of agent selection for PAH-directed therapy in patients with HIV</h1>
<div class="graphic"><div class="figure"><div class="ttl">Principles of agent selection for PAH-directed therapy in patients with HIV</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes">PAH: pulmonary arterial hypertension; HIV: human immune deficiency virus; NYHA: New York Heart Association; PDE5: phosphodiesterase type 5; ART: antiretroviral therapy.<br/>* The principles of agent selection are similar to those in the non-HIV-infected PAH population with the exception that calcium channel blockers be avoided. All patients should be managed by PAH and HIV experts who weigh the risks of drug interactions and benefits of a specific therapy.<br/>¶ No ART dose adjustments are needed for regimens that contain prostacyclin agonists (eg, epoprostenol, trepostinol, iloprost, selexipag) or the endothelin receptor atagonist, ambrisentan.<br/>◊ When modifying an ART regimen it is important to ensure the potency of the regimen and specific antiretroviral agents are preferred for patients with certain comorbid conditions (eg, chronic hepatitis B). Please refer to the topics that discusses switching regimens within UpToDate.</div><div id="graphicVersion">Graphic 116735 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
